Sponsored Research according to therapeutic area in Malaysia, 2025
Top therapeutic areas of sponsored research conducted in 2026 are in Oncology/hemato-onco, cardiology and paediatric
Phase breakdown of interventional studies in 2025
Phase III form the largest type of sponsored interventional research, followed by Phase II studies.
Top 10 Sites Based on IEC_IRB Approved Sponsored Research in 2025
Top 10 Trial Sites Based on IEC_IRB Approved Interventional Sponsored Research in 2025
Top Contributors in Number of New Sponsored Research by Sponsors for 2024
AstraZeneca, Novartis and Merck Sharp & Dohme
were the top 3 Sponsors in 2025
Top Contributors in Number of New Sponsored Research by CROs for 2024
IQVIA, PPD Thermo Fisher Scientific and PAREXEL
were the top 3 CROs in 2025
2025 Site Recruitment Achievements in Global Sponsored Trials
